BMI Calculation and Classification
For a 101 kg, 162 cm individual, the BMI is 38.5 kg/m², which classifies this person as having Class II obesity.
Calculation Method
BMI is calculated as weight in kilograms divided by height in meters squared 1. For this individual:
- Weight: 101 kg
- Height: 162 cm = 1.62 meters
- BMI = 101 ÷ (1.62)² = 101 ÷ 2.6244 = 38.5 kg/m²
Classification and Health Implications
This BMI of 38.5 kg/m² falls into Class II obesity (BMI 35-39.9 kg/m²), which is associated with significantly increased health risks 1.
Obesity Classification System:
- Overweight: BMI 25-29.9 kg/m²
- Class I Obesity: BMI 30-34.9 kg/m²
- Class II Obesity: BMI 35-39.9 kg/m² ← This patient
- Class III Obesity: BMI ≥40 kg/m² 1
Associated Health Risks at This BMI Level
At Class II obesity (BMI 38.5), this individual faces substantially elevated risks for multiple conditions 1:
- Cardiovascular disease: Significantly increased event rates compared to normal BMI 1
- Type 2 diabetes: Markedly elevated risk with metabolic dysfunction 1
- Hypertension: Increased blood pressure from excess adiposity 1
- Obstructive sleep apnea: From increased pharyngeal soft tissue 1
- Osteoarthritis: From mechanical joint loading 1
- Nonalcoholic fatty liver disease (MASLD): From visceral adiposity 1
Additional Assessment Recommended
Waist circumference should be measured as an additional risk stratification tool, though it becomes less reliable at BMI >35 1. Men with waist circumference >102 cm (>40 inches) and women >88 cm (>35 inches) have increased cardiovascular disease risk independent of BMI 1.
Treatment Implications at This BMI Level
At Class II obesity (BMI 38.5), this patient qualifies for aggressive multimodal treatment 1:
Lifestyle Intervention Target:
- Energy deficit of 500-1000 kcal/day to produce 1-2 pound weight loss per week 1
- High-intensity counseling (>1 session per month for at least 3 months) 1
- Combined nutrition education, physical activity, and behavioral strategies 1
Pharmacotherapy Eligibility:
- This patient meets criteria for weight-loss medications (BMI ≥30 or BMI ≥27 with complications) 1
- Medications should be used as adjunct to lifestyle interventions 1
- Continue only if ≥5% weight loss achieved in first 3 months 1
Bariatric Surgery Consideration:
- This patient is a candidate for bariatric surgery (BMI ≥35 with weight-related complications or BMI ≥40) 1
- Surgery should be considered when non-surgical interventions have failed 1
- Requires comprehensive multidisciplinary assessment before proceeding 1
- Long-term follow-up care mandatory for at least 2 years post-surgery 1
Clinical Approach
Screen for obesity-related complications including diabetes, hypertension, dyslipidemia, sleep apnea, and liver disease to guide treatment intensity 1. Assess for secondary causes such as hypothyroidism, hypercortisolism, medications causing weight gain, or psychiatric conditions like binge eating disorder 1.